SPOTLIGHT -
Dr. O’Malley on the Utility of Chemoimmunotherapy in Ovarian Cancer
David M. O'Malley, MD discusses the utility of chemoimmunotherapy in ovarian cancer.
Read More
Dr. O’Malley on the Efficacy of Pembrolizumab in Advanced Ovarian Cancer
David M. O'Malley, MD, discusses the efficacy of pembrolizumab in patients with advanced ovarian cancer.
The Future of Endometrial Cancer Treatment
Experts give insight on what they are looking forward to in the endometrial cancer space.
A Look at Surgical Innovations in EC
Nicoletta Colombo, MD, PhD, reviews surgical advancements in endometrial cancer.
Novel Targets of Interest in EC
Experts in endometrial cancer comment on novel targets of interest that are currently being investigated.
Insight on Ongoing Trials in EC
Key opinion leaders take a look at the evolving treatment landscape in endometrial cancer, discussing ongoing trials in the space.
Incorporating Molecular Features into Choosing Adjuvant Therapy
Experts discuss the importance of incorporating molecular features into the selection of adjuvant treatment.
Therapeutic Sequencing in Endometrial Cancer
Experts in endometrial cancer comment on therapeutic sequencing in endometrial cancer.
Managing AEs With Pembrolizumab and Lenvatinib
Key opinion leaders emphasize the importance of the management of adverse events in using pembrolizumab and lenvatinib.
Experience in Using Pembrolizumab + Lenvatinib in Advanced Endometrial Cancer
Experts give insight on their clinical use of pembrolizumab-lenvatinib. They highlight dose adjustments and the importance of the increased knowledge of adverse events.
A Discussion on the Study 309/KEYNOTE-775 Data
Key opinion leaders discuss the presented data from Study 309/KEYNOTE-775, highlighting patient reported outcomes, safety, and dosing.
Results from Study 309/KEYNOTE-775
Vicky Makker, MD, presents the results from Study 309/KEYNOTE-775, as well as key safety findings.
Study 309/KEYNOTE-775 Trial Design
Vicky Makker, MD, walks through the trial design of Study 309/KEYNOTE-775.
Therapeutic Approaches in Endometrial Cancer
Experts review optimal approaches to treatment in advanced endometrial cancer, touching on clinical trial data.
Biomarker Testing and Multidisciplinary Approaches in EC
Key opinion leaders share their thoughts on biomarker testing and multidisciplinary approaches for endometrial cancer at their institutions globally.
Heterogeneity of Endometrial Cancer
Experts in gynecologic cancer discuss the heterogeneity of endometrial cancer..
Promising Novel Targets for Endometrial Cancer Management
Novel Strategies in Development for EC Management
Therapy Sequencing Through Multiple Lines of Therapy in EC
Impact of Pembrolizumab/Lenvatinib Approval in EC
Safety/Efficacy Results From EC Cohort of KEYNOTE-146
Rationale for Combination Therapy in Advanced EC
GARNET Clinical Trial Regimen in Advanced Disease
Second-Line Checkpoint Inhibitor for MSI-H Disease
Adjuvant Chemotherapy +/- Radiotherapy: Recent Data
Treatment Challenges: Advanced Endometrial Cancer
Genomic Assessments for Metastatic Disease
Endometrial Cancer Incidence and Risk Classification
Future of Advanced Endometrial Cancer
Novel Targets for Advanced Endometrial Cancer
Medicaid Expansion Improves Survival in Pancreatic, Gastric Cancers, Potentially Reducing Disparities
Telephone-Based Weight Loss Program Is Effective for Breast Cancer Survivors
Pembrolizumab Plus Chemo With or Without Bevacizumab Maintains OS Benefit in Frontline Cervical Cancer
Minimally Invasive Distal Pancreatectomy Provides Effective Alternative in Resectable Pancreatic Cancer
